Loading clinical trials...
Loading clinical trials...
Randomized Double Blind Clinical Trial of Imiquimod (Aldara) Versus Placebo Used in Combination With Pentavalent Antimony (Glucantime) in Peruvian Cutaneous Leishmaniasis Patients
Conditions
Interventions
Imiquimod
Locations
2
Peru
UPCH
Cusco, Peru
IMT Alexander Von Humboldt
Lima, Peru
Start Date
December 1, 2005
Primary Completion Date
June 1, 2006
Completion Date
June 1, 2006
Last Updated
June 12, 2008
NCT06798402
NCT04268524
NCT06692985
NCT01300975
NCT03829917
NCT03023111
Lead Sponsor
Drugs for Neglected Diseases
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions